期刊论文详细信息
BMC Pediatrics
Randomized controlled trials in pediatric complementary and alternative medicine: Where can they be found?
David Moher3  Isola Ajiferuke1  Kaitryn Campbell2  Margaret Sampson4 
[1] Faculty of Information and Media Studies, The University of Western Ontario, Canada;The Ottawa Hospital, Canada;Department of Pediatrics, University of Ottawa, Canada;Chalmers Research Group, Children's Hospital of Eastern Ontario Research Institute, Canada
关键词: pediatrics, evidence-based medicine;    medical informatics applications;    information services;    bibliometrics;    alternative medicine;   
Others  :  1181737
DOI  :  10.1186/1471-2431-3-1
 received in 2002-05-28, accepted in 2003-02-14,  发布年份 2003
【 摘 要 】

Background

The safety and effectiveness of CAM interventions are of great relevance to pediatric health care providers. The objective of this study is to identify sources of reported randomized controlled trials (RCTs) in the field of pediatric complementary and alternative medicine (CAM).

Methods

Reports of RCTs were identified by searching Medline and 12 additional bibliographic databases and by reviewing the reference lists of previously identified pediatric CAM systematic reviews.

Results

We identified 908 reports of RCTs that included children under 18 and investigated a CAM therapy. Since 1965, there has been a steady growth in the number of these trials that are being published. The four journals that published the most reported RCTs are The American Journal of Clinical Nutrition, Pediatrics, Journal of Pediatrics, and Lancet. Medline, CAB Health, and Embase were the best database sources for identifying these studies; they indexed 93.2%, 58.4% and 42.2 % respectively of the journals publishing reports of pediatric CAM RCTs.

Conclusions

Those working or interested in the field of pediatric CAM should routinely search Medline, CAB Health and Embase for literature in the field. The four core journals identified above should be included in their collection.

【 授权许可】

   
2003 Sampson et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

附件列表
Files Size Format View
88KB Image download
Figure 2. 14KB Image download
Figure 1. 51KB Image download
【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】
  • [1]Panel on Definition and Description CRMCA1: Defining and describing complementary and alternative medicine. Alternative Therapies 1997, 3:49-57.
  • [2]Ottolini MC, Hamburger EK, Loprieato JO, Coleman RH, Sachs HC, Madden R, et al.: Complementary and alternative medicine use among children in the Washington, DC area. Ambul Pediatr 2001, 1:122-125.
  • [3]Sawni-Sikand A, Schubiner H, Thomas RL: Use of complementary/alternative therapies among children in primary care pediatrics. Ambul Pediatr 2002, 2:99-103.
  • [4]Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, et al.: Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002, 97:382-388.
  • [5]Ernst E: Herbal medicines: where is the evidence? BMJ 2000, 321:395-396.
  • [6]Complementary medicine: time for critical engagement. Lancet 2000, 356:2023.
  • [7]Moher D, Soeken K, Sampson M, Ben Porat L, Berman B: Assessing the quality of reports of systematic reviews in pediatric complementary and alternative medicine. BMC Pediatr 2002, 2:3. BioMed Central Full Text
  • [8]Moher D, Sampson M, Campbell K, Beckner W, Lepage L, Gaboury I, et al.: Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine. BMC Pediatr 2002, 2:2. BioMed Central Full Text
  • [9]The Cochrane Library. Oxford, Update Software 2001., (1)
  • [10]McKibbon A: PDQ Evidence-based principles and practice. Hamilton: BC Decker Inc 1998.
  • [11]Cochrane Complementary Medicine Field Registry Guidelines. 2001.
  • [12]Landis JR, Koch GG, Freeman JL, Freeman DHJ, Lehnen RC: A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 1977, 33:138-158.
  • [13]Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, et al.: A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI). Diabetes Metab Res Rev 1999, 15:181-185.
  • [14]Moher D, Pham , Klassen TP, Schulz KF, Berlin JA, Jadad AR, et al.: What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000, 53:964-972.
  • [15]Tang JL, Zhan SY, Ernst E: Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999, 319:160-161.
  • [16]Pittler MH, Abbot NC, Harkness EF, Ernst E: Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol 2000, 53:485-489.
  • [17]Counsell C: Formulating questions and locating primary studies for inclusion in systematic reviews. In In Systematic reviews: Synthesis of best evidence for health care decisions. Edited by Mulrow C, Cook D. Philadelphia: American College of Physicians; 1998.
  • [18]Nahim AM: Complementary medicine – new PubMed subset. NLM Technical Bulletin 2001, 318:e7.
  • [19]Clarke M, Oxman AD (Eds): The Cochrane Collaboration Handbook 4.1.1. In In The Cochrane Library. Oxford: Update Software; 2000.
  • [20]Avenell A, Handoll HHG, Grant AM: Lessons for search strategies from a systematic review, in The Cochrane Library, of nutritional supplementation trials in patients after hip fracture. Am J Clin Nutr 2001, 73:505-510.
  • [21]Sampson M, Barrowman NJ, Moher D, Klassen TP, Pham B, Platt R, et al.: Should meta-analysts search Embase in addition to Medline? Journal of Clinical Epidemiology 2003, in press.
  • [22]Kjaergard LL, Villumsen J, Gluud C: Quality of randomised clinical trials affects estimates of intervention efficacy. 7th Annual Cochrane Colloquium Abstracts, in RomeOctober 1999
  • [23]Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998, 352:609-613.
  • [24]Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
  • [25]Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, et al.: Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002, 287:2973-2982.
  • [26]Moss RL, Henry MC, Dimmitt RA, Rangel S, Geraghty N, Skarsgard ED: The role of prospective randomized clinical trials in pediatric surgery: state of the art? J Pediatr Surg 2001, 36:1182-1186.
  文献评价指标  
  下载次数:23次 浏览次数:8次